Status:

RECRUITING

Improved Diagnosis of Familial Hypercholesterolemia Across the Northland (ID-FH)

Lead Sponsor:

Essentia Health

Collaborating Sponsors:

Aspirus St. Luke's Hospital

WHITESIDE Institute for Clinical Research

Conditions:

Familial Hypercholesterolemia

Cholesterol, Elevated

Eligibility:

All Genders

2-75 years

Phase:

PHASE3

Brief Summary

The overall goal of this study is to promote awareness of Familial Hypercholesterolemia (FH). The investigators aim to enroll patients with suspected FH into the study and will randomize them to recei...

Detailed Description

This is a randomized 2-arm study designed to examine the impact of a personalized remote intervention that includes evidence-based risk communication and behavior change techniques with navigation. Pa...

Eligibility Criteria

Inclusion

  • Age 2-75 years
  • patients with existing clinical diagnosis or suspected FH
  • known genetic mutation of FH
  • patients with an initial (pretreatment) LDL level \>190 mg/dL or total cholesterol \>300 mg/dL (age \>19 years) or LDL-c \> 160mg/dL or total cholesterol \>260 mg/dL in children age 2-19 years
  • patients currently taking a lipid-lowering medication and have an LDL \>124 mg/dL or total cholesterol \>195 mg/dL
  • capable of providing informed consent
  • Patients should reside in Minnesota, Wisconsin or North Dakota.

Exclusion

  • Lack of research authorization
  • unable to provide informed consent (including non-English speaking individuals)
  • known medical condition other than FH that is thought to contribute to hyperlipidemia (i.e., untreated hypothyroidism, nephrotic syndrome, cholestasis hypopituitarism)
  • Pregnant women and prisoners will also be excluded.

Key Trial Info

Start Date :

February 15 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT05238519

Start Date

February 15 2022

End Date

December 1 2025

Last Update

February 3 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Aspirus St. Luke's Hospital

Duluth, Minnesota, United States, 55805

2

Essentia Health

Duluth, Minnesota, United States, 55805

Improved Diagnosis of Familial Hypercholesterolemia Across the Northland (ID-FH) | DecenTrialz